NCT04327570 In-depth Immunological Investigation of COVID-19.
| NCT ID | NCT04327570 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Condition | Coronavirus Infections |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2020-03-27 |
| Primary Completion | 2028-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2020-03-27 with a primary completion date of 2028-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The COntAGIouS trial (COvid-19 Advanced Genetic and Immunologic Sampling; an in-depth characterization of the dynamic host immune response to coronavirus SARS-CoV-2) proposes a transdisciplinary approach to identify host factors resulting in hyper-susceptibility to SARS-CoV-2 infection, which is urgently needed for directed medical interventions.
Eligibility Criteria
Inclusion Criteria: * Patients \>/= 18 years old AND * Hospitalised with PCR-confirmed and/or CT-confirmed SARS-CoV-2 disease Exclusion Criteria: * Age \< 18 years old * No informed consent
Contact & Investigator
Joost Wauters, MD PhD
PRINCIPAL INVESTIGATOR
UZ Leuven
Frequently Asked Questions
Who can join the NCT04327570 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Coronavirus Infections. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04327570 currently recruiting?
Yes, NCT04327570 is actively recruiting participants. Contact the research team at joost.wauters@uzleuven.com for enrollment information.
Where is the NCT04327570 trial being conducted?
This trial is being conducted at Leuven, Belgium.
Who is sponsoring the NCT04327570 clinical trial?
NCT04327570 is sponsored by Universitaire Ziekenhuizen KU Leuven. The principal investigator is Joost Wauters, MD PhD at UZ Leuven. The trial plans to enroll 100 participants.